PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Value Evidence and Outcomes, GSK, Brentford, England, UK. yumiko.x.asukai@gsk.com.\', \'London School of Hygiene and Tropical Medicine, London, England, UK.\', \'The Comparative Health Outcomes, Policy, and Economics Institute, University of Washington, Seattle, WA, USA.\', \'Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig Maximilian University, Munich, Germany.\', \'Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.\', \'Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s40273-021-01088-5
?:doi
?:hasPublicationType
?:journal
  • PharmacoEconomics
is ?:pmid of
?:pmid
?:pmid
  • 34557996
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.998
?:rankingScore_hIndex
  • 90
?:title
  • Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34557996>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34557996>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all